Company

Nicox S.A.

Nicox SA is a France-based ophthalmology company developing eye care therapeutics, founded in 1996.

About

Nicox SA is an ophthalmology company that develops novel therapeutics for eye diseases, with focus areas including glaucoma, allergic conjunctivitis and dry eye disease. Founded in 1996 and based in France, the company trades under the ticker EPA: ALCOX and was headed by CEO Gavin Spencer as of 2024. Visufarma S.p.A., a portfolio company of GHO Capital, acquired Nicox in August 2016.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in